Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial

Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH announcement about the terminology transition from “Artificial Intelligence” to “Super Intelligence,” along with its updates and FAQs link, is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T15:19:51.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.2 to v3.8.0; the study page remains an access-denied error.
    Difference
    0.2%
    Check dated 2026-11-01T16:30:32.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study page remains a 403 error page.
    Difference
    1%
    Check dated 2026-10-25T19:19:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T22:38:50.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:40:29.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating access to the record is blocked. This replaces the expected content with a standard error screen.
    Difference
    18%
    Check dated 2026-09-20T22:28:52.000Z thumbnail image

Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.